A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma
Status:
Withdrawn
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
This is a national, single arm, phase II trial in patients with diagnosis of unresectable or
advanced malignant pleural mesothelioma who experienced progression after platinum-based
chemotherapy.